4Filing Date: Aug 11, 2026

Dentsply Sirona (XRAY) 4: Frohning Andrea L. sold 802 shares at $12.12 on 2026-08-07 (Aug 11, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000818479-26-000266
Total Value$9.7K
Trades1
Insiders1

Transaction Details

Frohning Andrea L.
SVP, CHRO·Direct
Tax W/H · Dispose
Common Stock
Shares-802
Price$12.12
Total Value$9.7K
Shares Owned After63.19K
Transaction DateAug 7, 2026
Footnotes ▸

Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. | Total amount has been updated to reflect rounding as a result of dividend payments.

Post-Transaction Holdings

Frohning Andrea L. · SVP, CHRO
SecuritySharesChange
Common Stock63.19K-802 (-1.25%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-07 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: DENTSPLY SIRONA Inc. (XRAY) CIK: 0000818479 --- Reporting Owner --- Name: Frohning Andrea L. CIK: 0001591945 Role: Officer (SVP, CHRO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-07 | Code: F (Payment of exercise/tax) Shares: -802 | Price: $12.12 Total Value: $9,720.24 Shares Owned After: 63,190.618 | Ownership: D (Direct) Footnotes: [F1] Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. [F2] Total amount has been updated to reflect rounding as a result of dividend payments. --- Footnotes (Complete Index) --- F1: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. F2: Total amount has been updated to reflect rounding as a result of dividend payments. --- Signature --- /s/ /s/ Jessica Nielsen Causey, Attorney-in-Fact for Andrea Frohning (2026-08-11)

keid analysis is for reference only and does not constitute investment advice.